Typical versus atypical antipsychotics in first episode schizophrenia

被引：0

作者：

Altamura, AC ^{[1
]}

Sassella, F ^{[1
]}

Bassetti, R ^{[1
]}

Mundo, E ^{[1
]}

机构：

[1] Univ Milan, Osped L Sacco, Chair Psychiat, Milan, Italy

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S35 / S35

页数：1

相关论文

共 4 条

[1] Novel antipsychotics and the problem of clinical stabilization in schizophrenia: Are they ''stabilizer'' rather than typical compounds? [J].

Altamura, AC .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (03) :153-155

[2] Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study [J].

Altamura, AC ;

Bassetti, R ;

Sassella, F ;

Salvadori, D ;

Mundo, E .

SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) :29-36

[3] Olanzapine - An updated review of its use in the management of schizophrenia [J].

Bhana, N ;

Foster, RH ;

Olney, R ;

Plosker, GL .

DRUGS, 2001, 61 (01) :111-161

[4] Research and treatment strategies in first-episode psychoses - The Pittsburgh experience [J].

Keshavan, MS ;

Schooler, NR ;

Sweeney, JA ;

Haas, GL ;

Pettegrew, JW .

BRITISH JOURNAL OF PSYCHIATRY, 1998, 172 :60-65